An audit of the use of vigabatrin in the treatment of medically refractory epilepsy at a presurgical unit
To access this article, please choose from the options below
PII: S0896-6974(98)00033-4
doi:10.1016/S0896-6974(98)00033-4
© 1998 Published by Elsevier Inc.
